APA (7th ed.) Citation

Chen, D., Saltos, A. N., Rose, T., Thompson, Z. J., Thapa, R., Chiappori, A., & Gray, J. E. (2023). Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy. Cancers, 15(9), 2521. https://doi.org/10.3390/cancers15092521

Chicago Style (17th ed.) Citation

Chen, Dung-Tsa, Andreas N. Saltos, Trevor Rose, Zachary J. Thompson, Ram Thapa, Alberto Chiappori, and Jhanelle E. Gray. "Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy." Cancers 15, no. 9 (2023): 2521. https://doi.org/10.3390/cancers15092521.

MLA (9th ed.) Citation

Chen, Dung-Tsa, et al. "Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy." Cancers, vol. 15, no. 9, 2023, p. 2521, https://doi.org/10.3390/cancers15092521.